APYX MEDICAL CORP (APYX) Stock Analyst Earnings Estimates
NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 48.52M 75.10% | 44.51M -8.26% | 52.349M 17.61% | 48.226M -7.88% | 49.431M 2.50% | 53.058M 7.34% | 61.361M 15.65% | 75.183M 22.53% | 272.59M 262.57% | 361.19M 32.50% | |
| EBITDA YoY % growth | -13.55M 29.39% | -22.67M -67.31% | -19.259M 15.05% | -15.272M 20.70% | -4.608M 69.83% | -4.337M 5.89% | 5.814M 234.07% | 14.178M 143.86% | N/A | N/A | |
| EBIT YoY % growth | -14.45M 28.04% | -23.56M -63.04% | -19.951M 15.32% | -20.492M -2.71% | -10.153M 50.45% | -8.11M 20.13% | -1.534M 81.08% | 1.88M 222.55% | 40.889M 2,074.95% | 72.237M 76.67% | |
| Operating Margin | -29.78% | -52.93% | -38.11% | -42.49% | -20.54% | -15.28% | -2.50% | 2.50% | 15.00% | 20.00% | |
| EPS YoY % growth | -0.44 10.20% | -0.67 -52.27% | -0.62 7.46% | -0.72 -15.98% | -0.40 44.68% | -0.38 5.13% | -0.24 35.14% | -0.03 87.50% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 41.71% | -0.11 50.16% | -0.10 49.00% | -0.10 28.96% | -0.09 45.31% | -0.08 28.84% | -0.09 6.32% | -0.08 14.87% | -0.09 -6.29% |
| Revenue Q2Q % growth | 13.656M -6.86% | 10.42M 1.72% | 12.599M 3.70% | 12.015M 4.60% | 14.397M 5.43% | 11.439M 9.78% | 13.648M 8.33% | 12.893M 7.31% | 15.142M 5.17% |
| EBITDA Q2Q % growth | -2.931M 42.34% | -1.877M 70.93% | -1.008M 80.74% | -1.156M 63.64% | -566.783K 80.67% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.378M 24.21% | -3.126M 52.74% | -2.441M 56.00% | -2.605M 28.33% | -1.947M 55.52% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.14 -7.69% | -0.19 | 0.05 | 26.05% |
| Q2 2024 Q2Q % growth | -0.19 -72.73% | -0.20 | 0.01 | 6.02% |
| Q1 2024 Q2Q % growth | -0.22 -120.00% | -0.22 | 0.00 | -0.60% |
| Q4 2023 Q2Q % growth | -0.28 -64.71% | -0.18 | -0.10 | -54.57% |
| Q3 2023 Q2Q % growth | -0.13 23.53% | -0.12 | -0.01 | -12.59% |
| Q2 2023 Q2Q % growth | -0.11 31.25% | -0.07 | -0.04 | -55.39% |
| Q1 2023 Q2Q % growth | -0.10 41.18% | -0.14 | 0.04 | 27.38% |
| Q4 2022 Q2Q % growth | -0.17 -183.33% | -0.15 | -0.02 | -16.96% |
| Q3 2022 Q2Q % growth | -0.17 -41.67% | -0.15 | -0.02 | -14.94% |
| Q2 2022 Q2Q % growth | -0.16 -33.33% | -0.19 | 0.03 | 16.34% |
| Q1 2022 Q2Q % growth | -0.17 -21.43% | -0.15 | -0.02 | -13.63% |
| Q4 2021 Q2Q % growth | -0.06 -50.00% | -0.11 | 0.05 | 46.52% |
| Q3 2021 Q2Q % growth | -0.12 -9.09% | -0.15 | 0.03 | 21.57% |
| Q2 2021 Q2Q % growth | -0.12 14.29% | -0.15 | 0.03 | 20.10% |
| Q1 2021 Q2Q % growth | -0.14 30.00% | -0.15 | 0.01 | 3.68% |
| Q4 2020 Q2Q % growth | -0.04 75.00% | -0.11 | 0.07 | 64.99% |
| Q3 2020 Q2Q % growth | -0.11 15.38% | -0.17 | 0.06 | 34.74% |
| Q2 2020 Q2Q % growth | -0.14 -7.69% | -0.22 | 0.08 | 35.41% |
| Q1 2020 Q2Q % growth | -0.20 -42.86% | -0.26 | 0.05 | 21.57% |
| Q4 2019 Q2Q % growth | -0.16 | -0.20 | 0.04 | 18.83% |
| Q3 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q2 2019 Q2Q % growth | -0.13 | -0.18 | 0.05 | 29.19% |
| Q1 2019 Q2Q % growth | -0.14 | -0.18 | 0.04 | 23.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 11.487M -4.08% | 11.606M | -119K | -1.03% |
| Q2 2024 Q2Q % growth | 12.149M -10.47% | 11.982M | 167K | 1.39% |
| Q1 2024 Q2Q % growth | 10.244M -15.63% | 9.717M | 527K | 5.42% |
| Q4 2023 Q2Q % growth | 14.662M 16.27% | 15.145M | -483K | -3.19% |
| Q3 2023 Q2Q % growth | 11.976M 31.46% | 15.678M | -3.702M | -23.61% |
| Q2 2023 Q2Q % growth | 13.569M 31.87% | 14.612M | -1.043M | -7.14% |
| Q1 2023 Q2Q % growth | 12.142M -2.79% | 11.084M | 1.058M | 9.55% |
| Q4 2022 Q2Q % growth | 12.61M -25.03% | 13.195M | -585K | -4.43% |
| Q3 2022 Q2Q % growth | 9.11M -22.99% | 12.25M | -3.14M | -25.63% |
| Q2 2022 Q2Q % growth | 10.29M -8.29% | 10.768M | -478K | -4.44% |
| Q1 2022 Q2Q % growth | 12.49M 44.56% | 11.345M | 1.145M | 10.09% |
| Q4 2021 Q2Q % growth | 16.82M 46.77% | 14.919M | 1.901M | 12.74% |
| Q3 2021 Q2Q % growth | 11.83M 70.22% | 10.4M | 1.43M | 13.75% |
| Q2 2021 Q2Q % growth | 11.22M 160.93% | 9.039M | 2.181M | 24.13% |
| Q1 2021 Q2Q % growth | 8.64M 72.80% | 8.375M | 265K | 3.16% |
| Q4 2020 Q2Q % growth | 11.46M 35.46% | 9.808M | 1.652M | 16.84% |
| Q3 2020 Q2Q % growth | 6.95M -8.31% | 5.797M | 1.153M | 19.89% |
| Q2 2020 Q2Q % growth | 4.3M -35.34% | 2.004M | 2.296M | 114.57% |
| Q1 2020 Q2Q % growth | 5M -11.19% | 5.305M | -305K | -5.75% |
| Q4 2019 Q2Q % growth | 8.46M | 8.014M | 446K | 5.57% |
| Q3 2019 Q2Q % growth | 7.58M | 6.918M | 662K | 9.57% |
| Q2 2019 Q2Q % growth | 6.65M | 5.986M | 664K | 11.09% |
| Q1 2019 Q2Q % growth | 5.63M | 5.785M | -155K | -2.68% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.54% | 1.54% | 0.35% | 0.54% |
| Revenue | 2.87% | 2.87% | 0.8% | -6.87% |